Targeted Metabolomics Services

Microbiota-derived tryptophan metabolites

Updated 21/12/2022

What is measured?

3-Indoxyl sulfate (3IS), indole-3-acetamide (IAM), indole-3-acetate (IAA), indole-3-aldehyde (IAld), indole-3-lactate (ILA) and indole-3-propionate (IPA).
Method(s): LC-MS/MS (1).

Tryptophan metabolites of the indole pathway

About 5 % of tryptophan is catabolized by the gut microbome, generating so-called microbiome-derived tryptophan metabolites, which include indole (IND), 3-indoxyl sulfate (3IS), and indole derivatives, such as indole-3-acetamide (IAM), indole-3-acetate (IAA), indole-3-acetaldehyde (IAAld), indole-3-aldehyde (IAld), indole-3-acrylate (IacA) and indole-3-propionate (IPA).
Microbiome-derived tryptophan metabolites have diverse biological roles affecting health (Figure 1). Some are ligands of the aryl hydrocarbon receptor (AhR) thereby modulating the immune response, others have anti-inflammatory and anti-oxidative effects, enhance the intestinal epithelial barrier, increase secretion of gut hormones and stimulate intestinal motility. Indoles are generally thought to mediate beneficial health effects, with the exception of 3IS, a host-microbial co-metabolite generated from indole in the liver; 3IS is toxic at high concentrations and associated with vascular disease and renal dysfunction. 3IS is considered as uremic toxin, which is highly (90 %) bound to albumin, and therefore accumulates despite regular hemodialysis (2).


Profiling of microbiota-derived metabolites.

Specimen, collection and processing

Volume: Minimum volume is 60 µL, but 200 µL is optimal and allows reanalysis.
Preparation and stability: Samples should be put on ice immediately after collection and stored at -80 °C.


Frozen, on dry ice. (for general instruction on transportation, click here)

Reported values, interpretation

Reported values: 3IS: 0.9-30 µmol/L; IAM: 0-10 nmol/L; IAA: 0.3-23 µmol/L; IAld: 10-200 nmol/L; ILA: 0.08-5 µmol/L; IPA: 0.5-12 µmol/L.
Intraclass correlation coefficient (ICC): na.


1. Midttun, O., Hustad, S., and Ueland, P.M. (2009). Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Sp 23, 1371-79.
2. Roager, H. M., & Licht, T. R. (2018). Microbial tryptophan catabolites in health and disease. Nat Commun, 9, 3294.

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more

Scroll to Top

Join our Mailing list!

Get updates of our latest articles, events and method developments.